D
DW Eyre
Researcher at Public Health England
Publications - 4
Citations - 319
DW Eyre is an academic researcher from Public Health England. The author has contributed to research in topics: Vaccination & Viral load. The author has an hindex of 4, co-authored 4 publications receiving 129 citations.
Papers
More filters
Posted ContentDOI
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels,Koen B. Pouwels,Emma Pritchard,Emma Pritchard,Philippa C Matthews,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,DW Eyre,Vihta K-D.,Vihta K-D.,Thomas House,Thomas House,Jodie Hay,John I. Bell,John N Newton,Jeremy Farrar,D Crook,Duncan Cook,Emma Rourke,Ruth Studley,T Peto,Ian Diamond,Anne-Sophie Walker +23 more
TL;DR: The effectiveness of BNT162b2, ChAdOx1, and mRNA-1273 vaccines against new SARS-CoV-2 infections requires continuous re-evaluation, given the increasingly dominant Delta variant as mentioned in this paper.
Journal ArticleDOI
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
DW Eyre,S F Lumley,Jia Wei,Stuart Cox,Tim James,Anita Justice,Gerald Jesuthasan,Denise O'Donnell,Alison Howarth,Stephanie B Hatch,Brian D. Marsden,E Y Jones,David I. Stuart,Daniel Ebner,Sarah Hoosdally,Derrick W. Crook,T Peto,Timothy M Walker,Nicole Stoesser,Philippa C Matthews,Koen B. Pouwels,Anne-Sophie Walker,Anne-Sophie Walker,Katie Jeffery +23 more
TL;DR: In this paper, the determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following one or two doses of Pfizer-BioNTech or Oxford-AstraZeneca vaccines were investigated.
Posted ContentDOI
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey
Emma Pritchard,Emma Pritchard,Philippa C Matthews,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,DW Eyre,Owen Gethings,Karina-Doris Vihta,Karina-Doris Vihta,Joel Jones,Thomas House,Thomas House,H VanSteenHouse,I Bell,John I. Bell,John N Newton,Jeremy Farrar,Ian Diamond,Emma Rourke,Ruth Studley,D Crook,T Peto,Anne-Sophie Walker,Koen B. Pouwels,Koen B. Pouwels +25 more
TL;DR: In this article, the authors assessed the effectiveness of COVID-19 vaccination in preventing SARS-CoV-2 infection in the UK population-representative longitudinal COVID19 Infection Survey.
Journal ArticleDOI
Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
Sheila F Lumley,Bede Constantinides,Nicholas D Sanderson,Gillian Rodger,Teresa L Street,Jeremy Swann,Kevin K Chau,Denise O'Donnell,Fiona Warren,Sarah Hoosdally,Sarah Hoosdally,Control team,Control team,Anne-Marie O'Donnell,Timothy M. Walker,Nicole Stoesser,Lisa Butcher,Lisa Butcher,Tim E. A. Peto,Tim E. A. Peto,Derrick W. Crook,Katie Jeffery,Philippa C Matthews,DW Eyre +23 more
TL;DR: In this article, the authors investigated whether whole-genome sequencing enhanced the epidemiological investigation of healthcare-associated SARS-CoV-2 acquisition in hospitals and found that most nosocomial transmission occurs from a relatively limited number of highly infectious individuals.